loadpatents
Patent applications and USPTO patent grants for MUSSMANN; Rainer.The latest application filed is for "anti-cd40 antibodies for use in treatment of tidm and insulitis".
Patent | Date |
---|---|
Anti-cd40 Antibodies For Use In Treatment Of Tidm And Insulitis App 20220195061 - ESPIE; Pascal ;   et al. | 2022-06-23 |
Novel Neurturin Conjugates For Pharmaceutical Use App 20160060317 - Austen; Matthias ;   et al. | 2016-03-03 |
Neurturin conjugates for pharmaceutical use Grant 9,029,323 - Austen , et al. May 12, 2 | 2015-05-12 |
Novel Neurturin Conjugates For Pharmaceutical Use App 20130231283 - Austen; Matthias ;   et al. | 2013-09-05 |
Use of azapaullones for preventing and treating pancreatic autoimmune disorders Grant 7,968,535 - Mussmann , et al. June 28, 2 | 2011-06-28 |
Novel Neurturin Conjugates For Pharmaceutical Use App 20110003741 - Austen; Matthias ;   et al. | 2011-01-06 |
Use of Azapaullones For Preventing and Treating Pancreatic Autoimmune Disorders App 20080287423 - Mussmann; Rainer ;   et al. | 2008-11-20 |
Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders App 20080207594 - Mussmann; Rainer ;   et al. | 2008-08-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.